期刊文献+

基于倾向评分法的丹红注射液联合使用胰岛素安全性研究 被引量:4

Security study based on the propensity score method of Danhong Injection combined with insulin
原文传递
导出
摘要 目的:评价临床丹红注射液配伍使用胰岛素的安全性。方法:采用医院集中监测法收集丹红注射液与胰岛素合并使用信息,使用倾向评分法进行数据处理分析,比较与Logistic回归得出的OR值。结果:倾向评分法和传统Logistic回归法得出丹红注射液不良反应与是否联合使用胰岛素的OR值分别为0.19[0.03,1.41]和0.22[0.03,1.57]。结论:联合使用胰岛素不会增加丹红注射液的用药风险。 Objective: To evaluate the safety of Danhong Injection combined with insulin in clinical. Methods: The information of Danhong Injection combined with insulin was collected by using the method of hospital centralized monitoring. The results were statistically analyzed by using the propensity score method and the Logistic regression analysis. To compare two dif erent results. Results: The OR values of Danhong Injection ADR and whether combined with insulin or not were 0.19 [0.03, 1.41] and 0.22 [0.03, 1.57]respectively by using the propensity score method and the traditional Logistic regression. Conclusion: Danhong Injection combined with insulin could not increase the risk of medication.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2014年第7期2141-2143,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家"十一五"重大新药创制专项(No.2009ZX09502-030)~~
关键词 倾向评分 丹红注射液 胰岛素 安全性 Propensity score Danhong Injection Insulin Security
  • 相关文献

参考文献11

二级参考文献74

共引文献99

同被引文献60

  • 1周飞舟,贾树雅,章浩,明华,黄艳,刘敏.丹红注射液联合胰岛素及山莨菪碱治疗糖尿病足的观察[J].中药药理与临床,2008,24(6):75-76. 被引量:11
  • 2刘志峰,李春梅,李敏,李慎军,刘珂.α-糖苷酶抑制剂阿卡波糖的临床药理作用[J].中国药理学通报,2004,20(9):965-968. 被引量:29
  • 3周超凡,徐植灵,林育华.中药注射剂的回顾和展望[J].中国中药杂志,2006,31(24):2094-2096. 被引量:51
  • 4国家食品药品监督管理总局.国家药品不良反应监测年度报告(2013年)[EB/OL].2014-05-14.http://www.sds.gov.en/WS01/CL0078/99794.html.
  • 5国家食品药品监督管理总局.国家药品不良反应监测年度报告(2014年)[EB/OL].(2015-07-17)[2015-08-02]]http://www.cfda.gov.cn/WS01/CL0078/124407.html.
  • 6Chen J, Deng J, Zhang Y Y, et al. Lipid-lowering effects of Danhong injection on hyperlipidemia rats [ J ]. J Ethnopharmacol, 2014, 154: 437.
  • 7Wang D D, Fan G W, Wang Y F, et al. Vascular reactivityscreen of Chinese medicine Danhong injection identifies danshen- su as a NO-independent but PGl2-mediated relaxation factor[J]. J Cardiovasc Pharmacol, 2013, 62(5) : 457.
  • 8Su X M, Zhi X W, Cui T, et al. Vasorelaxant activities of Dan- hong injection and their differential effects on the rat abdominal aorta and mesenteric artery[ J]. J Cardiovasc Pharmacol, 2015, 65(1) : 62.
  • 9He Y, Wan H T, Du Y G, et al. Protective effect of Danhong in- jection on cerebral ischemia-repeffusion injury in rats [ J]. J Eth- nopharmacol, 2012, 144: 387.
  • 10Liu H T, Wang Y F, Olaleye O, et al. Characterization of in vivo antioxidant constituents and dual-standard quality assessment of Danhong injection[J~. Biomed Chromatogr, 2013, 27: 655.

引证文献4

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部